Blackrock Neurotech is a pioneering company that develops innovative neurotechnology solutions, including brain-computer interface (BCI) systems, to improve the lives of patients with paralysis and other neurological disorders. Their breakthrough technologies enable individuals to perform daily tasks and activities using only their thoughts, offering new hope and independence to those with neurological conditions.

Marcus Gerhardt

Florian Solzbacher

Blackrock Neurotech

Global Equity Partners GmbH is currently under construction.  Further information can be found in the company's Impressum.

Global Equity Partners

BlackPoint Capital is a boutique advisory practice providing independent merchant banking services. BlackPoint provides strategic, financial, and tactical advice on mergers, acquisitions, and corporate divestitures, as well as financial advice on capital raising alternatives.

BlackPoint Capital

Capital Wealth Management, LLC provides financial advisory services including investment planning, retirement planning, tax planning, and estate planning.

Capital Wealth Management, LLC

Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today.

Connect with us: 
Join Our Team | https://bit.ly/3bCsXRv 
LinkedIn | https://bit.ly/3PfifOL 
Twitter | https://bit.ly/3PfifOL 
Instagram | https://bit.ly/3bMaYrW 
Facebook | https://bit.ly/3JRc2av
Clinical Trials | https://bit.ly/3A8QPWm
Our site | https://blackrockneurotech.com

Additional information: 
As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications. 

Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023. 

Join us in changing lives today.

Kliwla Family Office AG

What If Ventures

WPSS.bio

Presight Capital

Sorenson Impact

re.Mind Capital

Peter Thiel

Tim Sievers

In a significant step forward in medical science, researchers from Northwell Health’s Feinstein Institutes for Medical Research have successfully conducted the first double neural bypass operation - employing our Utah Array. 

Keith Thomas, a 45-year-old man paralyzed from the chest down due to a diving accident, is the first to experience the transformative results of this operation. 

The researchers successfully implanted our Utah Array into specific regions of Thomas's brain to stimulate motion and feeling. When Thomas visualizes a movement, our device captures the electrical signals in his brain and relays them to a computer that decodes the signals and stimulates the appropriate muscles, thus facilitating the movement Thomas imagines.

The same process aids in restoring Thomas's sense of touch. Sensors on his skin send signals to the computer, which communicates with the Utah Arrays in his brain, enabling him to experience tactile sensations once again. Post-operation, Thomas has demonstrated significant progress, regaining the ability to move his arms and feel sensations on his skin.

This operation marks a remarkable advancement in paralysis research and brain-computer interfacing, taking a giant leap forward in our understanding and ability to restore mobility and sensation in individuals affected by paralysis.

Read the full TIME story and watch Keith's story here: https://lnkd.in/g9exCUhW

#BCI #Neurotech #Medtech #Neuroscience #Technology #Paralysis #Braincomputerinterface

I am hiring for a sales role at Blackrock Neurotech! It's a real challenge to find someone to fit this niche role. Sales experience is a must, but so is a passion for academic neuroscience research. Please share with anyone who may be interested in selling the tools that fuel cutting edge animal and human intracranial research.

Blackrock Neurotech technology meets the brilliance of University of California, San Francisco minds.


#BCI #medtech #ALS #ai

Chips on your mind? 🍟

The idea of having a chip installed on your brain brings thoughts of a dystopian nightmare for many. 

The recent news from Neuralink shows its now a reality and I was surprised to find out that BlackRock owned competitor, Blackrock Neurotech has been implanting brain-computer interfaces since 2004 🤯.

They've installed 50 chips similar to the Neuralink's one to date and so we now have a competitive market of privately owned companies that are developing technology which will be symbiotic with your thoughts. 🧠🤖

What a time to be alive!

During the early 19th century people were terrified to get on a train for the first time as they feared its speed would kill them...

It didn't and now we can't recognise a world without the locomotive.🚂 

Are we right to be scared by the prospect of advanced brain-computer interfaces becoming a norm, or are we on the cusp of a technological revolution that will thrust humanity forward for the better? 🤔

Umbilical Technology

#neuralink #neurotech #computationalbiology #elonmusk #tech

A new piece in Scientific Reports from Stanford University, Brown University, and Harvard Medical School's visionary researchers showcases a truly groundbreaking advancement in implantable BCI technology: Recurrent neural network-enabled control over multiple effectors.

This innovation opens the door to bimanual tasks and movements—imagine controlling two computer cursors or operating dual robotic arms simultaneously, all through the power of thought.
 
This work provides critical insight, tackle the longstanding challenge of interpreting complex and nonlinear neural signals. By employing recurrent neural networks, the team has unlocked high-quality, bimanual control, fine-tuning the system to distinguish between left and right-hand movements effectively.

A core element of this study is Blackrock Neurotech’s technology. Our 96-channel intracortical microelectrode arrays (Utah Arrays), placed within the participant's precentral gyrus, and NeuroPort system were instrumental in capturing and processing the neural signals necessary for this achievement.

This leap in BCI capability is not just a milestone in neurotech, but a notable advancement in the continuation of unlocking new frontiers and possibility.

Read the full article here: https://lnkd.in/ek4svyqA
 
#BCI #Neurotech #Medtech #AI #Neuralnetworks #Neuroscience

Fabulous perspectives on Brain Implants led by Nandan Lad Duke University  with Ian Burkhart, Benjamin Rapoport of Precision Neuroscience  Florian Solzbacher at Blackrock Neurotech  and Devjani Saha of MCRA

Some people think they have cool friends, but I actually have the coolest friends. Nathan Copeland created this BCI masterpiece by connecting his thoughts directly to his computer using Blackrock Neurotech’s at-home system. 

If you’re a little (or a lot) jealous that you don’t have a cool mind-made art piece, you’re in luck. Nathan has a select few signed prints available here: https://lnkd.in/eP8UmCMq

Kind of a perfect holiday present for yourself or the neuroscientist you love. 

Thank you guy! 🦾

Our webinar begins in 30 minutes. Register here, and see you soon: https://lnkd.in/e37DmPyX

Really looking forward to talk about my research in Brain-Machine Interfaces this Friday at 12PM EST! Sign up to the webinar if you're interested.

We're hosting a webinar this Friday with Dr. Sarah Kim Wandelt. You aren't going to want to miss it. Register here: https://lnkd.in/e37DmPyX

Metric
Company Name	Blackrock Neurotech	Global Equity Partners	BlackPoint Capital	Capital Wealth Management, LLC
Symbol
MSH ID	COM:BLACKROCKNEUROTECH	AT:GEP	COM:BLACKPOINTCAPITAL	COM:CAPITALWM
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance	Financial Services & Finance	Financial Services & Finance
Industry	Healthcare & Health Services	Investment Management	Investment Management	Financial Advisory Services
Country	US	AT	US	US
Stage
Employee Count	134
Website	blackrockneurotech.com	gep.at	blackpointcapital.com	capitalwm.com
LinkedIn	blackrock-neurotech
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	7.28K	768	294
Web Traffic Growth	0.53	-0.53
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BLACKROCKNEUROTECH

Blackrock Neurotech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue